Claudio Fozza

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Hematological oncology

Annals of hematology

American journal of hematology

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Luca Lanino, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Marta Riva, Angela Consagra, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Raffaele Palmieri, Antonella Poloni, Catello Califano, Isabella Capodanno, Federico Itri, Chiara Elena, Claudio Fozza, Fabrizio Pane, Anna Maria Pelizzari, Massimo Breccia, Francesco Di Bassiano, Elena Crisà, Dario Ferrero, Valentina Giai, Daniela Barraco, Antonella Vaccarino, Davide Griguolo, Paola Minetto, Martina Quintini, Stefania Paolini, Grazia Sanpaolo, Mariarosaria Sessa, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Livia Leuzzi, Angelo Genua, Attilio Guarini, Alfredo Molteni, Barbara Nicolino, Ubaldo Occhini, Giulia Rivoli, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Felicetto Ferrara, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Marco Frigeni, Rosaria Sancetta, Carmine Selleri, Ilaria Tanasi, Patrizia Tosi, Mauro Turrini, Laura Giordano, Carlo Finelli, Paolo Pasini, Ilaria Naldi, Valeria Santini, Matteo Giovanni Della Porta, null null
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. American journal of hematology (2023)
Christian Bichard, Illaria Mancini, Pasquale Agosti, Marco Capecchi, Pasqualina De Leo, Sara Arcudi, Barbara Ferrari, Silvia Maria Trisolini, Francesco Longu, Claudio Fozza, Andrea Artoni, Flora Peyvandi
Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura. Blood advances 6 (18) (2022)
Gloria Acquaviva, Giovanna Nonne, Andrea Murtas, Francesco Longu, Giovanni Caocci, Giorgio La Nasa, Claudio Fozza
Cytomegalovirus reactivation in patients under immunosuppressive treatment for autoimmune haemolytic anaemia. Annals of hematology (2021)
Olga Mulas, Giovanni Caocci, Mario Annunziata, Bruno Martino, Luigiana Luciano, Fausto Castagnetti, Patrizia Pregno, Sara Galimberti, Francesco Albano, Ester M Orlandi, Nicola Sgherza, Alessandra Iurlo, Massimiliano Bonifacio, Gianni Binotto, Antonella Gozzini, Monica Bocchia, Elisabetta Abruzzese, Claudio Fozza, Maria P Simula, Fiorenza De Gregorio, Gabriele Gugliotta, Francesca Pirillo, Claudia Baratè, Imma Attolico, Chiara Elena, Daniele Cattaneo, Luigi Scaffidi, Anna Sicuranza, Malgorzata M Trawinska, Emilia Scalzulli, Robin Foà, Massimo Breccia, Giorgio La Nasa
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib. Hematological oncology 38 (4) (2020)
Antonio Carruale, Francesco Longu, Francesca Mura, Giovanni Caocci, Giorgio La Nasa, Claudio Fozza
Occurrence of immune thrombocytopenic purpura in a patient with essential thrombocythemia: How the immune system can overcome a neoplastic clone. Clinical case reports 8 (11) (2020)
Giovanni Caocci, Olga Mulas, Elisabetta Abruzzese, Luigiana Luciano, Alessandra Iurlo, Immacolata Attolico, Fausto Castagnetti, Sara Galimberti, Nicola Sgherza, Massimiliano Bonifacio, Mario Annunziata, Antonella Gozzini, Ester Maria Orlandi, Fabio Stagno, Gianni Binotto, Patrizia Pregno, Claudio Fozza, Malgorzata Monika Trawinska, Fiorenza De Gregorio, Daniele Cattaneo, Francesco Albano, Gabriele Gugliotta, Claudia Baratè, Luigi Scaffidi, Chiara Elena, Francesca Pirillo, Emilia Scalzulli, Giorgio La Nasa, Robin Foà, Massimo Breccia
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart. Hematological oncology 37 (3) (2019)
Giovanni Caocci, Olga Mulas, Mario Annunziata, Luigiana Luciano, Massimiliano Bonifacio, Ester Maria Orlandi, Patrizia Pregno, Sara Galimberti, Antonella Russo Rossi, Elisabetta Abruzzese, Alessandra Iurlo, Bruno Martino, Nicola Sgherza, Gianni Binotto, Fausto Castagnetti, Antonella Gozzini, Claudio Fozza, Monica Bocchia, Anna Sicuranza, Fabio Stagno, Fabio Efficace, Emilio Usala, Fiorenza De Gregorio, Luigi Scaffidi, Chiara Elena, Francesca Pirillo, Claudia Baratè, Malgorzata Monika Trawinska, Daniele Cattaneo, Claudia Labate, Gabriele Gugliotta, Matteo Molica, Giorgina Specchia, Giorgio La Nasa, Robin Foà, Massimo Breccia
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis. American journal of hematology 93 (7) (2018)
Claudio Fozza
Deciphering the prognostic significance of autoimmune disorders in myelodysplastic syndromes. Annals of hematology 98 (4) (2018)
Claudio Fozza
The burden of autoimmunity in myelodysplastic syndromes. Hematological oncology 36 (1) (2017)

Claudio Fozza.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Claudio Fozza